{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:24:06Z","timestamp":1790472246822,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"22","license":[{"start":{"date-parts":[[2005,7,28]],"date-time":"2005-07-28T00:00:00Z","timestamp":1122508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,7,28]],"date-time":"2005-07-28T00:00:00Z","timestamp":1122508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2005,11,1]]},"DOI":"10.1038\/sj.gt.3302549","type":"journal-article","created":{"date-parts":[[2005,7,28]],"date-time":"2005-07-28T21:03:18Z","timestamp":1122584598000},"page":"1618-1632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL"],"prefix":"10.1038","volume":"12","author":[{"given":"D","family":"Sondhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E L","family":"Giannaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C T","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B S","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A B","family":"Rostkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Bjugstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"J R","family":"Sladek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"D E","family":"Redmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P L","family":"Leopold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S M","family":"Kaminsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N R","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R G","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,7,28]]},"reference":[{"key":"BF3302549_CR1","unstructured":"Lysosomal enzymes. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Stanbury JB, Wyngaarden JB, Fredrickson DS (eds). The Metabolic and Molecular Basis of Inherited Disease. McGraw-Hill, Inc.: New York, 1995, p 2427."},{"key":"BF3302549_CR2","first-page":"37","volume-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","author":"RE Williams","year":"1999","unstructured":"Williams RE et al. CLN 2. Classic Late Infantile NCL. In: Goebel HH, Mole SE, Lake BD (eds). The Neuronal Ceroid Lipofuscinoses (Batten Disease). IOS Press: Amsterdam, 1999, p 37."},{"key":"BF3302549_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jnen\/62.1.1","volume":"62","author":"M Haltia","year":"2003","unstructured":"Haltia M . The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol 2003; 62: 1\u201313.","journal-title":"J Neuropathol Exp Neurol"},{"key":"BF3302549_CR4","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","volume":"277","author":"DE Sleat","year":"1997","unstructured":"Sleat DE et al. Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 1997; 277: 1802\u20131805.","journal-title":"Science"},{"key":"BF3302549_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0014-5793(98)01683-4","volume":"443","author":"DJ Vines","year":"1999","unstructured":"Vines DJ, Warburton MJ . Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I. FEBS Lett 1999; 443: 131\u2013135.","journal-title":"FEBS Lett"},{"key":"BF3302549_CR6","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ajmg.1320420428","volume":"42","author":"DN Palmer","year":"1992","unstructured":"Palmer DN et al. Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am J Med Genet 1992; 42: 561\u2013567.","journal-title":"Am J Med Genet"},{"key":"BF3302549_CR7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s004010050661","volume":"93","author":"F Umehara","year":"1997","unstructured":"Umehara F et al. Accumulation of mitochondrial ATP synthase subunit c in muscle in a patient with neuronal ceroid lipofuscinosis (late infantile form). Acta Neuropathol 1997; 93: 628\u2013632.","journal-title":"Acta Neuropathol"},{"key":"BF3302549_CR8","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1046\/j.1471-4159.1999.0722573.x","volume":"72","author":"J Ezaki","year":"1999","unstructured":"Ezaki J, Tanida I, Kanehagi N, Kominami E . A lysosomal proteinase, the late infantile neuronal ceroid lipofuscinosis gene (CLN2) product, is essential for degradation of a hydrophobic protein, the subunit c of ATP synthase. J Neurochem 1999; 72: 2573\u20132582.","journal-title":"J Neurochem"},{"key":"BF3302549_CR9","first-page":"671","volume-title":"Handbook of Clinical Neurology (Vol. 22, 66): Neurodystrophies and Neurolipidoses","author":"RM Boustany","year":"1996","unstructured":"Boustany RM . Batten disease or neuronal ceroid lipofuscinosis. In: Moser HW (ed). Handbook of Clinical Neurology (Vol. 22, 66): Neurodystrophies and Neurolipidoses. Elsevier Science B.V.: New York, 1996, p 671."},{"key":"BF3302549_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1006\/mgme.1999.2829","volume":"66","author":"DG Birch","year":"1999","unstructured":"Birch DG . Retinal degeneration in retinitis pigmentosa and neuronal ceroid lipofuscinosis: an overview. Mol Genet Metab 1999; 66: 356\u2013366.","journal-title":"Mol Genet Metab"},{"key":"BF3302549_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng1094-148","volume":"8","author":"MG Kaplitt","year":"1994","unstructured":"Kaplitt MG et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148\u2013154.","journal-title":"Nat Genet"},{"key":"BF3302549_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0006-8993(95)01488-8","volume":"713","author":"TJ McCown","year":"1996","unstructured":"McCown TJ et al. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 1996; 713: 99\u2013107.","journal-title":"Brain Res"},{"key":"BF3302549_CR13","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/sj.gt.3300650","volume":"5","author":"MJ During","year":"1998","unstructured":"During MJ et al. In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Therapy 1998; 5: 820\u2013827.","journal-title":"Gene Therapy"},{"key":"BF3302549_CR14","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1523\/JNEUROSCI.18-11-04271.1998","volume":"18","author":"RJ Mandel","year":"1998","unstructured":"Mandel RJ et al. Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease. J Neurosci 1998; 18: 4271\u20134284.","journal-title":"J Neurosci"},{"key":"BF3302549_CR15","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1073\/pnas.97.7.3428","volume":"97","author":"BL Davidson","year":"2000","unstructured":"Davidson BL et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA 2000; 97: 3428\u20133432.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302549_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1006\/mthe.2001.0274","volume":"3","author":"WA Frisella","year":"2001","unstructured":"Frisella WA et al. Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII. Mol Ther 2001; 3: 351\u2013358.","journal-title":"Mol Ther"},{"key":"BF3302549_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/sj.gt.3301843","volume":"10","author":"RE Haskell","year":"2003","unstructured":"Haskell RE et al. Viral-mediated delivery of the late-infantile neuronal ceroid lipofuscinosis gene, TPP-I to the mouse central nervous system. Gene Theapy 2003; 10: 34\u201342.","journal-title":"Gene Theapy"},{"key":"BF3302549_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1006\/exnr.1999.7176","volume":"160","author":"AF Skorupa","year":"1999","unstructured":"Skorupa AF et al. Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice. Exp Neurol 1999; 160: 17\u201327.","journal-title":"Exp Neurol"},{"key":"BF3302549_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1006\/mthe.1999.0005","volume":"1","author":"A Bosch","year":"2000","unstructured":"Bosch A, Perret E, Desmaris N, Heard JM . Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors. Mol Ther 2000; 1: 63\u201370.","journal-title":"Mol Ther"},{"key":"BF3302549_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1089\/10430340050015707","volume":"11","author":"TJ Sferra","year":"2000","unstructured":"Sferra TJ et al. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse. Hum Gene Ther 2000; 11: 507\u2013519.","journal-title":"Hum Gene Ther"},{"key":"BF3302549_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1042\/bj3570049","volume":"357","author":"L Lin","year":"2001","unstructured":"Lin L, Lobel P . Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis. Biochem J 2001; 357: 49\u201355.","journal-title":"Biochem J"},{"key":"BF3302549_CR22","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1074\/jbc.M008562200","volume":"276","author":"L Lin","year":"2001","unstructured":"Lin L, Sohar I, Lackland H, Lobel P . The human CLN2 protein\/tripeptidyl-peptidase I is a serine protease that autoactivates at acidic pH. J Biol Chem 2001; 276: 2249\u20132255.","journal-title":"J Biol Chem"},{"key":"BF3302549_CR23","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1086\/302427","volume":"64","author":"DE Sleat","year":"1999","unstructured":"Sleat DE et al. Mutational analysis of the defective protease in classic late-infantile neuronal ceroid lipofuscinosis, a neurodegenerative lysosomal storage disorder. Am J Hum Genet 1999; 64: 1511\u20131523.","journal-title":"Am J Hum Genet"},{"key":"BF3302549_CR24","doi-asserted-by":"publisher","first-page":"9117","DOI":"10.1523\/JNEUROSCI.2729-04.2004","volume":"24","author":"DE Sleat","year":"2004","unstructured":"Sleat DE et al. A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration. J Neurosci 2004; 24: 9117\u20139126.","journal-title":"J Neurosci"},{"key":"BF3302549_CR25","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1128\/jvi.70.11.8098-8108.1996","volume":"70","author":"XF Xiao","year":"1996","unstructured":"Xiao XF, Li JF, Samulski RJ . Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 1996; 70: 8098\u20138108.","journal-title":"J Virol"},{"key":"BF3302549_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/10430349950018995","volume":"10","author":"WD Lo","year":"1999","unstructured":"Lo WD et al. Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression. Hum Gene Ther 1999; 10: 201\u2013213.","journal-title":"Hum Gene Ther"},{"key":"BF3302549_CR27","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1128\/JVI.78.6.3110-3122.2004","volume":"78","author":"CE Thomas","year":"2004","unstructured":"Thomas CE, Storm TA, Huang Z, Kay MA . Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors. J Virol 2004; 78: 3110\u20133122.","journal-title":"J Virol"},{"key":"BF3302549_CR28","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1006\/mthe.2001.0520","volume":"5","author":"BK Kaspar","year":"2002","unstructured":"Kaspar BK et al. Targeted retrograde gene delivery for neuronal protection. Mol Ther 2002; 5: 50\u201356.","journal-title":"Mol Ther"},{"key":"BF3302549_CR29","doi-asserted-by":"publisher","first-page":"6437","DOI":"10.1523\/JNEUROSCI.22-15-06437.2002","volume":"22","author":"MA Passini","year":"2002","unstructured":"Passini MA, Lee EB, Heuer GG, Wolfe JH . Distribution of a lysosomal enzyme in the adult brain by axonal transport and by cells of the rostral migratory stream. J Neurosci 2002; 22: 6437\u20136446.","journal-title":"J Neurosci"},{"key":"BF3302549_CR30","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1001\/archneur.58.11.1793","volume":"58","author":"D Sondhi","year":"2001","unstructured":"Sondhi D et al. Feasibility of gene therapy for late neuronal ceroid lipofuscinosis. Arch Neurol 2001; 58: 1793\u20131798.","journal-title":"Arch Neurol"},{"key":"BF3302549_CR31","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/sj.gt.3301420","volume":"8","author":"TM Daly","year":"2001","unstructured":"Daly TM et al. Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer. Gene Therapy 2001; 8: 1291\u20131298.","journal-title":"Gene Therapy"},{"key":"BF3302549_CR32","doi-asserted-by":"publisher","first-page":"12382","DOI":"10.1128\/JVI.75.24.12382-12392.2001","volume":"75","author":"MA Passini","year":"2001","unstructured":"Passini MA, Wolfe JH . Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector. J Virol 2001; 75: 12382\u201312392.","journal-title":"J Virol"},{"key":"BF3302549_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1006\/exnr.2002.7942","volume":"176","author":"RL Klein","year":"2002","unstructured":"Klein RL et al. Dose and promoter effects of adeno-associated viral vector for green fluorescent protein expression in the rat brain. Exp Neurol 2002; 176: 66\u201374.","journal-title":"Exp Neurol"},{"key":"BF3302549_CR34","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1089\/10430340252837206","volume":"13","author":"RL Klein","year":"2002","unstructured":"Klein RL, King MA, Hamby ME, Meyer EM . Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra. Hum Gene Ther 2002; 13: 605\u2013612.","journal-title":"Hum Gene Ther"},{"key":"BF3302549_CR35","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1515\/bchm3.1996.377.3.195","volume":"377","author":"S Prosch","year":"1996","unstructured":"Prosch S et al. Inactivation of the very strong HCMV immediate early promoter by DNA CpG methylation in vitro. Biol Chem Hoppe Seyler 1996; 377: 195\u2013201.","journal-title":"Biol Chem Hoppe Seyler"},{"key":"BF3302549_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1046-2023(02)00227-X","volume":"28","author":"HL Fitzsimons","year":"2002","unstructured":"Fitzsimons HL, Bland RJ, During MJ . Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain. Methods 2002; 28: 227\u2013236.","journal-title":"Methods"},{"key":"BF3302549_CR37","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1089\/hum.1998.9.8-1181","volume":"9","author":"JS Bartlett","year":"1998","unstructured":"Bartlett JS, Samulski RJ, McCown TJ . Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum Gene Ther 1998; 9: 1181\u20131186.","journal-title":"Hum Gene Ther"},{"key":"BF3302549_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0006-8993(98)00169-3","volume":"793","author":"NL Chamberlin","year":"1998","unstructured":"Chamberlin NL, Du B, de Lacalle S, Saper CB . Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS. Brain Res 1998; 793: 169\u2013175.","journal-title":"Brain Res"},{"key":"BF3302549_CR39","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/cne.902350304","volume":"235","author":"SN Haber","year":"1985","unstructured":"Haber SN, Groenewegen HJ, Grove EA, Nauta WJ . Efferent connections of the ventral pallidum: evidence of a dual striato pallidofugal pathway. J Comp Neurol 1985; 235: 322\u2013335.","journal-title":"J Comp Neurol"},{"key":"BF3302549_CR40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/0306-4522(89)90128-0","volume":"29","author":"AJ McGeorge","year":"1989","unstructured":"McGeorge AJ, Faull RL . The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 1989; 29: 503\u2013537.","journal-title":"Neuroscience"},{"key":"BF3302549_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/cne.902990206","volume":"299","author":"HW Berendse","year":"1990","unstructured":"Berendse HW, Groenewegen HJ . Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum. J Comp Neurol 1990; 299: 187\u2013228.","journal-title":"J Comp Neurol"},{"key":"BF3302549_CR42","first-page":"1589","volume":"12","author":"MJ During","year":"2001","unstructured":"During MJ, Kaplitt MG, Stern MB, Eidelberg D . Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation. Hum Gene Ther 2001; 12: 1589\u20131591.","journal-title":"Hum Gene Ther"},{"key":"BF3302549_CR43","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1089\/104303402760128612","volume":"13","author":"C Janson","year":"2002","unstructured":"Janson C et al. Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain. Hum Gene Ther 2002; 13: 1391\u20131412.","journal-title":"Hum Gene Ther"},{"key":"BF3302549_CR44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","volume":"108","author":"H Niwa","year":"1991","unstructured":"Niwa H, Yamamura K, Miyazaki J . Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991; 108: 193\u2013199.","journal-title":"Gene"},{"key":"BF3302549_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1089\/10430349950019219","volume":"10","author":"TM Daly","year":"1999","unstructured":"Daly TM et al. Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice. Hum Gene Ther 1999; 10: 85\u201394.","journal-title":"Hum Gene Ther"},{"key":"BF3302549_CR46","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1073\/pnas.96.5.2296","volume":"96","author":"TM Daly","year":"1999","unstructured":"Daly TM et al. Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease. Proc Natl Acad Sci USA 1999; 96: 2296\u20132300.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302549_CR47","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1089\/hum.1998.9.18-2745","volume":"9","author":"D Grimm","year":"1998","unstructured":"Grimm D, Kern A, Rittner K, Kleinschmidt JA . Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther 1998; 9: 2745\u20132760.","journal-title":"Hum Gene Ther"},{"key":"BF3302549_CR48","first-page":"S47","volume":"5","author":"JP Qui","year":"2002","unstructured":"Qui JP, Mendez BS, Crystal RG, Hackett NR . Construction and verification of an Ad\/AAV helper plasmid designed for manufacturing recombinant AAV vectors for human administration. Mol Ther 2002; 5: S47\u2013S48.","journal-title":"Mol Ther"},{"key":"BF3302549_CR49","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1128\/jvi.70.7.4646-4654.1996","volume":"70","author":"S Zolotukhin","year":"1996","unstructured":"Zolotukhin S et al. A \u2018humanized\u2019 green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 1996; 70: 4646\u20134654.","journal-title":"J Virol"},{"key":"BF3302549_CR50","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/sj.gt.3300938","volume":"6","author":"S Zolotukhin","year":"1999","unstructured":"Zolotukhin S et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Therapy 1999; 6: 973\u2013985.","journal-title":"Gene Therapy"},{"key":"BF3302549_CR51","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1089\/hum.1995.6.10-1329","volume":"6","author":"KR Clark","year":"1995","unstructured":"Clark KR, Voulgaropoulou F, Fraley DM, Johnson PR . Cell lines for the production of recombinant adeno-associated virus. Hum Gene Ther 1995; 6: 1329\u20131341.","journal-title":"Hum Gene Ther"},{"key":"BF3302549_CR52","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1128\/jvi.70.9.6497-6501.1996","volume":"70","author":"DE Brough","year":"1996","unstructured":"Brough DE et al. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. J Virol 1996; 70: 6497\u20136501.","journal-title":"J Virol"},{"key":"BF3302549_CR53","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/oxfordjournals.jbchem.a022781","volume":"128","author":"J Ezaki","year":"2000","unstructured":"Ezaki J, Takeda-Ezaki M, Kominami E . Tripeptidyl peptidase I, the late infantile neuronal ceroid lipofuscinosis gene product, initiates the lysosomal degradation of subunit c of ATP synthase. J Biochem (Tokyo) 2000; 128: 509\u2013516.","journal-title":"J Biochem (Tokyo)"},{"key":"BF3302549_CR54","first-page":"88","volume-title":"Quantitative Methods in Neuroscience-A Stereological Approach","author":"DA Peterson","year":"2004","unstructured":"Peterson DA . The use of fluorescent probes in cell counting procedures. In: Evans SM, Janson AM, Nyengaard JR (eds). Quantitative Methods in Neuroscience-A Stereological Approach. Oxford University Press: Oxford, 2004, p 88."},{"key":"BF3302549_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1096-9861(19990201)404:1<1::AID-CNE1>3.0.CO;2-#","volume":"404","author":"DA Peterson","year":"1999","unstructured":"Peterson DA et al. Central neuronal loss and behavioral impairment in mice lacking neurotrophin receptor p75. J Comp Neurol 1999; 404: 1\u201320.","journal-title":"J Comp Neurol"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302549.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302549","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302549.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:07:19Z","timestamp":1648613239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,28]]},"references-count":55,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2005,11,1]]}},"alternative-id":["BF3302549"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302549","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,28]]},"assertion":[{"value":"22 July 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}